Alector drops in after-hours trading after upper-level management shakeup

Alector Inc. President and Chief Operating Officer Shehnaaz Suliman and Chief Medical Officer Dr. Robert Paul will step from their posts, the South San Francisco neurology drug developer said Tuesday. The moves, disclosed after markets closed, sent Alector's stock (NASDAQ: ALEC) down nearly 6% to $25.14 per share...

Click to view original post